Characterization of cytokine/chemokine profiles of severe acute respiratory syndrome
Y Jiang, J Xu, C Zhou, Z Wu, S Zhong, J Liu… - American journal of …, 2005 - atsjournals.org
Rationale: There is currently no optimal treatment or effective drug for severe acute
respiratory syndrome (SARS), because the immunopathologic mechanism is poorly …
respiratory syndrome (SARS), because the immunopathologic mechanism is poorly …
Temporal changes in cytokine/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome
Objective and background: Pathological changes in severe acute respiratory syndrome
(SARS) suggest that SARS sequelae are associated with dysregulation of cytokine and …
(SARS) suggest that SARS sequelae are associated with dysregulation of cytokine and …
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong, CWK Lam, AKL Wu, WK Ip… - Clinical & …, 2004 - academic.oup.com
Severe acute respiratory syndrome (SARS) is a recently emerged infectious disease caused
by a novel coronavirus, but its immunopathological mechanisms have not yet been fully …
by a novel coronavirus, but its immunopathological mechanisms have not yet been fully …
Analysis of serum cytokines in patients with severe acute respiratory syndrome
Y Zhang, J Li, Y Zhan, L Wu, X Yu, W Zhang… - Infection and …, 2004 - Am Soc Microbiol
Severe acute respiratory syndrome (SARS) is an acute infectious disease of the respiratory
system. Although a novel coronavirus has been identified as the causative agent of SARS …
system. Although a novel coronavirus has been identified as the causative agent of SARS …
Early enhanced expression of interferon-inducible protein-10 (CXCL-10) and other chemokines predicts adverse outcome in severe acute respiratory syndrome
Background: Exaggerated activation of cytokines/chemokines has been proposed as a
factor in adverse outcome of severe acute respiratory syndrome (SARS). Previous studies …
factor in adverse outcome of severe acute respiratory syndrome (SARS). Previous studies …
Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome.
WH Sheng, BL Chiang, SC Chang, HN Ho… - Journal of the …, 2005 - europepmc.org
Background and purpose Severe acute respiratory syndrome (SARS) is a highly
transmissible disease with significant morbidity and mortality. Death from SARS is most often …
transmissible disease with significant morbidity and mortality. Death from SARS is most often …
Altered p38 mitogen-activated protein kinase expression in different leukocytes with increment of immunosuppressive mediators in patients with severe acute …
CH Lee, RF Chen, JW Liu, WT Yeh… - The Journal of …, 2004 - journals.aai.org
Severe acute respiratory syndrome (SARS) has spread to a global pandemic, especially in
Asia. The transmission route of SARS has been clarified, but the immunopathogenesis of …
Asia. The transmission route of SARS has been clarified, but the immunopathogenesis of …
Molecular pathology in the lungs of severe acute respiratory syndrome patients
J Ye, B Zhang, J Xu, Q Chang, MA McNutt… - The American journal of …, 2007 - Elsevier
Severe acute respiratory syndrome (SARS) is a novel infectious disease with disastrous
clinical consequences, in which the lungs are the major target organs. Previous studies …
clinical consequences, in which the lungs are the major target organs. Previous studies …
[HTML][HTML] Severe acute respiratory syndrome: clinical and laboratory manifestations
CWK Lam, MHM Chan, CK Wong - The Clinical Biochemist …, 2004 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome (SARS) is a recently emerged infectious disease with
significant morbidity and mortality. An epidemic in 2003 affected 8,098 patients in 29 …
significant morbidity and mortality. An epidemic in 2003 affected 8,098 patients in 29 …
[HTML][HTML] Expression profile of immune response genes in patients with severe acute respiratory syndrome
R Reghunathan, M Jayapal, LY Hsu, HH Chng, D Tai… - BMC immunology, 2005 - Springer
Background Severe acute respiratory syndrome (SARS) emerged in later February 2003, as
a new epidemic form of life-threatening infection caused by a novel coronavirus. However …
a new epidemic form of life-threatening infection caused by a novel coronavirus. However …